Treatment of Cellulitis at Cesarean Section Site
For cellulitis at a C-section incision site, empirical antibiotic therapy should cover both β-hemolytic streptococci and MRSA given the surgical wound context and high prevalence of MRSA in post-cesarean infections. 1, 2
Outpatient Management (Mild Cases)
For patients without systemic signs of infection who can be managed as outpatients:
Recommended oral antibiotic options that cover both streptococci and MRSA:
- Clindamycin 300-450 mg PO three times daily (provides dual coverage as monotherapy) 1
- TMP-SMX 1-2 double-strength tablets twice daily PLUS amoxicillin 500 mg three times daily (combination provides dual coverage) 1
- Doxycycline 100 mg twice daily PLUS amoxicillin 500 mg three times daily (combination provides dual coverage) 1
- Linezolid 600 mg twice daily (dual coverage but more expensive) 1
Duration: 5-10 days, individualized based on clinical response 1
Why MRSA Coverage is Critical Here
Post-cesarean wound infections have a 53% MRSA prevalence based on culture data, making it the most common pathogen isolated from C-section wound infections 2. This is a surgical/traumatic wound infection, which falls under the IDSA criteria for empirical MRSA coverage 3, 1.
Inpatient Management (Complicated Cases)
Hospitalization is indicated for:
- Systemic signs of infection (fever, tachycardia, hypotension)
- Rapidly progressive infection
- Failed outpatient therapy
- Extensive cellulitis involving multiple tissue planes
- Immunocompromised status or significant comorbidities 3, 1
Recommended IV antibiotic options:
- Vancomycin 15-20 mg/kg IV every 8-12 hours (first-line for complicated SSTI) 1
- Linezolid 600 mg IV twice daily 1
- Daptomycin 4 mg/kg IV once daily 1
- Clindamycin 600 mg IV three times daily (if local MRSA clindamycin resistance <10%) 1
Duration: 7-14 days based on clinical response 1
Critical Management Steps
Source Control
- Examine wound carefully for abscess or fluid collection - if present, incision and drainage is mandatory 3, 1
- Remove any necrotic tissue or foreign material
- Consider imaging (ultrasound or CT) if deeper infection suspected 3
Culture Guidance
Obtain wound cultures before starting antibiotics when treating with systemic antibiotics, especially for surgical site infections 1. This allows de-escalation to narrower spectrum therapy once susceptibilities return.
Avoid These Pitfalls
Do NOT use TMP-SMX or tetracyclines as monotherapy - they lack reliable activity against β-hemolytic streptococci, which remain important pathogens in surgical wound infections 1
Do NOT use rifampin - either alone or as adjunctive therapy for SSTI 1
Do NOT assume this is "nonpurulent cellulitis" - C-section site infections are surgical/traumatic wound infections that warrant MRSA coverage even without visible purulence 3, 1
Special Considerations for Postpartum Women
- Breastfeeding compatibility: Clindamycin, cephalosporins, and penicillins are generally compatible with breastfeeding
- TMP-SMX caution: Avoid in mothers of infants <2 months old due to risk of kernicterus 1
- Tetracyclines: Generally compatible with breastfeeding despite older concerns
When to Reassess
If no clinical improvement within 48-72 hours, consider:
- Treatment failure due to resistant organism (obtain cultures if not done)
- Deeper infection (abscess, necrotizing fasciitis, endometritis)
- Alternative diagnosis (hematoma, seroma, allergic reaction)
- Need for surgical intervention 3, 1
The key distinction here is recognizing that C-section site cellulitis represents a surgical/traumatic wound infection, not simple nonpurulent cellulitis, which fundamentally changes the empirical antibiotic approach to mandate MRSA coverage from the outset 3, 1, 2.